Bio-Techne Corp (NASDAQ: TECH) kicked off on Tuesday, up 1.42% from the previous trading day, before settling in for the closing price of $62.80. Over the past 52 weeks, TECH has traded in a range of $51.79-$89.91.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 12.42%. While this was happening, its average annual earnings per share was recorded -11.95%. With a float of $155.57 million, this company’s outstanding shares have now reached $157.64 million.
Let’s determine the extent of company efficiency that accounts for 3050 employees.
Bio-Techne Corp (TECH) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Bio-Techne Corp is 1.03%, while institutional ownership is 100.29%. The most recent insider transaction that took place on Mar 07 ’24, was worth 800,627. In this transaction Director of this company sold 10,400 shares at a rate of $76.98, taking the stock ownership to the 43,097 shares. Before that another transaction happened on Aug 30 ’23, when Company’s Director sold 8,939 for $80.32, making the entire transaction worth $717,959. This insider now owns 51,872 shares in total.
Bio-Techne Corp (TECH) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2023, the organization reported 0.53 earnings per share (EPS), higher than consensus estimate (set at 0.53) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -11.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.56% during the next five years compared to 16.30% growth over the previous five years of trading.
Bio-Techne Corp (NASDAQ: TECH) Trading Performance Indicators
Take a look at Bio-Techne Corp’s (TECH) current performance indicators. Last quarter, stock had a quick ratio of 3.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.74. Likewise, its price to free cash flow for the trailing twelve months is 44.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.39, a number that is poised to hit 0.45 in the next quarter and is forecasted to reach 2.03 in one year’s time.
Technical Analysis of Bio-Techne Corp (TECH)
Looking closely at Bio-Techne Corp (NASDAQ: TECH), its last 5-days average volume was 1.01 million, which is a drop from its year-to-date volume of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 17.55%. Additionally, its Average True Range was 1.95.
During the past 100 days, Bio-Techne Corp’s (TECH) raw stochastic average was set at 14.39%, which indicates a significant decrease from 25.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.96% in the past 14 days, which was lower than the 31.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $70.19, while its 200-day Moving Average is $71.48. However, in the short run, Bio-Techne Corp’s stock first resistance to watch stands at $64.33. Second resistance stands at $64.97. The third major resistance level sits at $65.35. If the price goes on to break the first support level at $63.31, it is likely to go to the next support level at $62.92. Should the price break the second support level, the third support level stands at $62.28.
Bio-Techne Corp (NASDAQ: TECH) Key Stats
The company with the Market Capitalisation of 10.01 billion has total of 157,192K Shares Outstanding. Its annual sales at the moment are 1,137 M in contrast with the sum of 285,260 K annual income. Company’s last quarter sales were recorded 272,600 K and last quarter income was 27,470 K.
